Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
NCT00829179
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Allergic Asthma
Interventions
DRUG:
RhuMab-E25
Sponsor
Duke University
Collaborators
[object Object]